WO1999063935A3 - Cure rapide de desintoxication aux opioïdes et traitement contre la rechute toxicomaniaque - Google Patents

Cure rapide de desintoxication aux opioïdes et traitement contre la rechute toxicomaniaque Download PDF

Info

Publication number
WO1999063935A3
WO1999063935A3 PCT/US1999/012763 US9912763W WO9963935A3 WO 1999063935 A3 WO1999063935 A3 WO 1999063935A3 US 9912763 W US9912763 W US 9912763W WO 9963935 A3 WO9963935 A3 WO 9963935A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
detoxification
readdiction
patient
rapid
Prior art date
Application number
PCT/US1999/012763
Other languages
English (en)
Other versions
WO1999063935A2 (fr
Original Assignee
U S Detox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S Detox Inc filed Critical U S Detox Inc
Priority to AU44259/99A priority Critical patent/AU4425999A/en
Publication of WO1999063935A2 publication Critical patent/WO1999063935A2/fr
Publication of WO1999063935A3 publication Critical patent/WO1999063935A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Abstract

Cette invention est une cure rapide de désintoxication aux opioïdes consistant à calmer le patient au moyen d'un agent anesthésiant à courte période de récupération complète. On administre au patient un antagoniste d'opioïde pendant que le sédatif fait effet. Le patient peut reprendre un régime ambulatoire dans les huit heures suivant le début du traitement. Cette cure de désintoxication comporte également une administration d'un antidiarrhéique tel que l'octréotide à l'état acétate pour limiter cet effet délétère de la cure de désintoxication. L'invention concerne également un traitement permettant de réduire les symptômes liés au sevrage aux opiacés et consistant en une administration d'un antagoniste du GABAB.
PCT/US1999/012763 1998-06-09 1999-06-08 Cure rapide de desintoxication aux opioïdes et traitement contre la rechute toxicomaniaque WO1999063935A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU44259/99A AU4425999A (en) 1998-06-09 1999-06-08 Rapid opioid detoxification therapy and anti-readdiction therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9415298A 1998-06-09 1998-06-09
US09/094,152 1998-06-09

Publications (2)

Publication Number Publication Date
WO1999063935A2 WO1999063935A2 (fr) 1999-12-16
WO1999063935A3 true WO1999063935A3 (fr) 2000-04-13

Family

ID=22243481

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/012763 WO1999063935A2 (fr) 1998-06-09 1999-06-08 Cure rapide de desintoxication aux opioïdes et traitement contre la rechute toxicomaniaque

Country Status (2)

Country Link
AU (1) AU4425999A (fr)
WO (1) WO1999063935A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
US5173282A (en) * 1991-10-04 1992-12-22 Mobil Oil Corp. Synthesis of crystalline mordenite-type material
US5272149A (en) * 1992-05-05 1993-12-21 Stalling Reginald W Symptom controlled receptor substitution for addiction withdrawl

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
US5173282A (en) * 1991-10-04 1992-12-22 Mobil Oil Corp. Synthesis of crystalline mordenite-type material
US5272149A (en) * 1992-05-05 1993-12-21 Stalling Reginald W Symptom controlled receptor substitution for addiction withdrawl

Also Published As

Publication number Publication date
WO1999063935A2 (fr) 1999-12-16
AU4425999A (en) 1999-12-30

Similar Documents

Publication Publication Date Title
WO1999011250A3 (fr) Noribogaine utilisee pour le traitement de la douleur et de la toxicomanie
Day et al. The mechanism of the antihypertensive action of α-methyldopa in hypertensive rats
CA2549801A1 (fr) Amelioration des fonctions renales par le treprostinil
US20070167438A1 (en) Treatment of substance abuse
WO2003080022A3 (fr) Analgesiques
JPH03163030A (ja) アヘン剤活性を選択的に強化し、アヘン剤耐性と依存性を軽減するための組成物と方法
US5919760A (en) Method for treating acute and severe diarrhea
Varon et al. Naloxone reversal of hypotension due to captopril overdose
Sher The placebo effect on mood and behavior: the role of the endogenous opioid system
WO2006012603A3 (fr) Analogues de l'isovaleramide, composition pharmaceutique contenant ces analogues et methode permettant de traiter des maladies ou des affections du systeme nerveux central
EP1292305B1 (fr) Utilisation du l-threo-methylphenidate pour la preparation d'un medicament pour le traitement des troubles d'rodre psychotique
WO1999063935A3 (fr) Cure rapide de desintoxication aux opioïdes et traitement contre la rechute toxicomaniaque
WO2004010923A3 (fr) Apport de composes a l'encephale par modification de proprietes de la barriere hemato-encephalique et de la circulation cerebrale
Pabone et al. Strain-dependent effects of shock-induced release of opioids: dissociation between analgesia and behavioral seizures
Pilcher et al. Rhythmic nature of naloxone-induced aversions and nociception in rats
EP1392301B1 (fr) Prevention de l'accoutumance dans le soulagement de la douleur avec gamma vinyl gaba
Zsigmond et al. Nalbuphine as an analgesic component in balanced anesthesia for cardiac surgery
Lindeburg et al. Respiratory, analgesic and endocrine responses to an enkephalin analogue in normal man
EP1145716A3 (fr) Agent thérapeutique pour traitement de la dermatite
WO2003072019A3 (fr) Therapie sequentielle comprenant un compose 20(s)-camptothecine et un analogue de base pyrimidine
Prieto et al. Ultrarapid high-dose methadone detoxification
Salem et al. Atropine or glycopyrrolate with neostigmine 5 mg: A comparative dose-response study
Broadley et al. The use of meptazinol as a premedication for surgical patients
WO1997012634A1 (fr) NOUVELLE COMBINAISON D'UN AGENT DE BLOCAGE DE β-RECEPTEUR ET D'UN OPIACE
Dib A study of intracerebroventricular self-administration of leucine or methionine enkephalin by rats in response to intermittent electric shocks

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase